<--- Back to Details
First PageDocument Content
Pluristem Therapeutics / Ischemia
Date: 2013-12-18 05:50:25
Pluristem Therapeutics
Ischemia

Add to Reading List

Source URL: pluristem.com

Download Document from Source Website

File Size: 56,77 KB

Share Document on Facebook

Similar Documents

Pluristem Issues Letter to Shareholders HAIFA, Israel, February 07, Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapy products, today reported financial resu

DocID: 1uCYz - View Document

Finance / Money / Economy / Corporate finance / Equity securities / Stock market / Options / Warrant / Pluristem Therapeutics / NASDAQ / Stock / Security

Ellenoff Grossman & Schole LLP 2015 Representative Registered Direct Transactions Areas of Practice Include: Pluristem Therapeutics

DocID: 1pWA5 - View Document

Stem cells / Pluristem Therapeutics / Technion Israel Institute of Technology / ReWalk / Hematopoietic stem cell transplantation / Ars / Bone marrow / Israel

ISRAEL Small Country BIG IDEAS The disabled may walk again M ore than 2 million Americans may be able to walk again despite their lower limb disabilities

DocID: 1puwc - View Document

Pluristem Therapeutics / Technion Israel Institute of Technology / Stem cells / Peripheral artery disease / Critical limb ischemia / Cell therapy / Ischemia / Clinical trial / Forward-looking statement / Amputation

Pluristem - PR - Effectiveness of PLX Cells (B1964939).DOCX

DocID: 1p3Oj - View Document

Pluristem Therapeutics / Globes / Cell therapy / Biology / Hypertension / Pulmonary hypertension

PDF Document

DocID: mC0V - View Document